Sunita D Nasta Selected Research

CTL019 chimeric antigen receptor

12/2018

Early positron emission tomography/computed tomography as a predictor of response after CTL019 chimeric antigen receptor -T-cell therapy in B-cell non-Hodgkin lymphomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sunita D Nasta Research Topics

Disease

15	Lymphoma (Lymphomas) 01/2022 - 02/2002
13	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 03/2004
9	Neoplasms (Cancer) 03/2021 - 03/2004
8	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 03/2021 - 01/2011
6	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 06/2003
5	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2022 - 07/2009
4	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2019 - 01/2014
4	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2019 - 04/2010
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 12/2019 - 08/2005
3	Hodgkin Disease (Hodgkin's Disease) 01/2019 - 04/2017
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 07/2012
2	Infections 01/2021 - 08/2013
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2019 - 01/2018
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2019 - 11/2009
2	Disease Progression 10/2013 - 04/2010
1	Neutropenia 01/2022
1	Burkitt Lymphoma (Burkitt's Lymphoma) 03/2021
1	COVID-19 01/2021
1	Cytokine Release Syndrome 12/2018
1	Inflammation (Inflammations) 12/2018
1	Glomerulonephritis 01/2018
1	Pathologic Complete Response 12/2017
1	Bites and Stings (Sting) 02/2017
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2016
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2016
1	Hematologic Neoplasms (Hematological Malignancy) 07/2015
1	Cytopenia 08/2013
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 08/2013
1	Philadelphia Chromosome 08/2013
1	Sezary Syndrome (Sezary Erythroderma) 02/2012
1	Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy) 04/2007
1	Paraproteinemias (Monoclonal Gammopathy) 10/2005
1	Carcinoma (Carcinomatosis) 09/2005
1	Radiodermatitis 09/2005
1	Pericardial Effusion 09/2005
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 03/2004

Drug/Important Bio-Agent (IBA)

7	Rituximab (Mabthera)FDA Link 12/2017 - 01/2011
6	Chimeric Antigen ReceptorsIBA 01/2022 - 12/2017
4	tisagenlecleucelIBA 01/2022 - 12/2017
3	Monoclonal AntibodiesIBA 02/2017 - 06/2003
2	pembrolizumabIBA 01/2022 - 02/2017
2	Bexarotene (LGD1069)FDA Link 01/2021 - 08/2005
2	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 12/2017
2	ibrutinibIBA 01/2019 - 01/2018
2	Immune Checkpoint InhibitorsIBA 01/2019 - 02/2017
2	Immunoglobulin M (IgM)IBA 12/2017 - 03/2004
2	Lenalidomide (CC 5013)FDA Link 04/2015 - 01/2014
2	Pharmaceutical PreparationsIBA 01/2014 - 02/2012
1	Immune Checkpoint ProteinsIBA 03/2021
1	Brentuximab VedotinIBA 01/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	axicabtagene ciloleucelIBA 01/2020
1	venetoclaxIBA 12/2019
1	CTL019 chimeric antigen receptorIBA 12/2018
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	Immunoglobulin G (IgG)IBA 12/2017
1	Immunoglobulin A (IgA)IBA 12/2017
1	Temozolomide (Temodar)FDA LinkGeneric 12/2017
1	AntigensIBA 02/2017
1	blinatumomabIBA 02/2017
1	NivolumabIBA 02/2017
1	Proteins (Proteins, Gene)FDA Link 02/2017
1	AntibodiesIBA 02/2017
1	Etoposide (VP 16)FDA LinkGeneric 01/2016
1	Anaplastic Lymphoma KinaseIBA 01/2016
1	nelarabine (506U78)FDA Link 01/2016
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2014
1	Vorinostat FDA Link 02/2012
1	Histone Deacetylase InhibitorsIBA 02/2012
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2011
1	NucleosidesIBA 01/2011
1	Phosphates (Orthophosphate)IBA 01/2011
1	Prednisone (Sone)FDA LinkGeneric 01/2011
1	Choline (Choline Chloride)IBA 01/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2011
1	Vincristine (Oncovin)FDA LinkGeneric 01/2011
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2011
1	triphosphoric acid (triphosphate)IBA 01/2011
1	Cytotoxins (Cytolysins)IBA 11/2009
1	TOR Serine-Threonine KinasesIBA 11/2009
1	Sirolimus (Rapamycin)FDA Link 11/2009
1	denileukin diftitox (Ontak)FDA Link 04/2007
1	Blood Proteins (Serum Proteins)IBA 10/2005
1	Gemcitabine FDA Link 09/2005
1	RetinoidsIBA 08/2005
1	tositumomab I-131 (Bexxar)FDA Link 03/2004
1	IodineIBA 03/2004

Therapy/Procedure

21	Therapeutics 01/2022 - 02/2002
9	Drug Therapy (Chemotherapy) 01/2018 - 06/2003
5	Stem Cell Transplantation 09/2017 - 10/2013
3	Hematopoietic Stem Cell Transplantation 01/2022 - 07/2012
3	Radiotherapy 01/2020 - 02/2014
2	Immunotherapy 12/2018 - 02/2017
2	Organ Transplantation 10/2005 - 08/2005
2	Radioimmunotherapy 03/2004 - 06/2003
1	Off-Label Use 12/2019
1	Transplantation 12/2017
1	Induction Chemotherapy 08/2013
1	Contraindications 09/2005